third time's a charm: erc advanced grant for marc koper
Published 3 years ago • 859 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:04
three leiden science professors receive erc advanced grant
-
1:25
ewine van dishoeck receives erc advanced grant for research into the chemistry of new worlds
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
0:46
update of emerald by duration of cdk4/6i in metastatic setting: elacestrant v soc in er /her2- mbc
-
2:00
rapides regional health talk - pupilometer
-
20:37
gs2-02: "elacestrant, an oral selective estrogen receptor degrader (serd), vs investigator’s..."
-
16:10
emerald study lead to the elacestrant fda approval - oncbrothers in discussion w/ dr. aditya bardia
-
44:50
ads3/rmt2 duality - eric perlmutter
-
8:43
cso | escrs 2019 - erik mertens, md, febophth
-
2:12
mwhc regional cancer center truebeam linear accelerator ribbon cutting
-
1:54
accuray @ estro 2024 - interview with klara stefansson
-
1:58
codebreak100: detecting mechanisms of intrinsic resistance by ctdna
-
2:21
updated results by duration of prior cdk4/6i in the met setting of the phase iii emerald trial
-
4:39
serd vs investigator’s choice of endocrine monotherapy for er /her2-advanced/mbc
-
0:30
the impact of the emerald trial results based on duration of prior cdk4/6i in the metastatic setting
-
2:35
what does the future hold for serds in er breast cancer?
-
3:07
highlights from sabcs 2021: t-dxd, keynote-355, pada-1 & emerald
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
3:57
eos - cms advanced materials technology
-
2:25
harvard university | accruent case study | ems
-
1:00
highlights from the san antonio breast cancer symposium 2022